- Statin use was associated with decreased risk for venous thromboembolism (VTE) in women with endometrial cancer.
- Aspirin or statin+aspirin use did not lower risk for VTE.
Why this matters
- Gynecologic cancers are associated with an increased risk of venous thromboembolism.
- If confirmed in prospective studies, statins may reduce risk for VTE in obese women and those with aggressive tumors.
- Multi-center study of 2527 women with primary endometrial cancer during 2000-2015.
- 15.5% of patients received statin and 8.7% received aspirin.
- Funding: Ensign Endowment for Gynecologic Cancer Research.
- Median follow-up time, 43.0 months.
- 132 women were diagnosed with VTE; 5-year cumulative incidence rate, 6.1%.
- The most common events were deep vein thrombosis (DVT, 59.8%), followed by DVT+pulmonary embolism (PE; 23.5%), and PE (16.7%).
- Statin use was associated with 58% lower risk for VTE vs non-use (2.5% vs 6.7%; aHR, 0.42; P=.030).
- The impact of aspirin on VTE risk was not statistically significant (P=.24).
- No significant joint effect of dual statin and aspirin use was observed (Pinteraction=.090).
- Prognostic factors for statin VTE risk-reduction benefit included obesity, absence of diabetes mellitus, type II histology, and recurrent disease (all Pinteraction<.05>
- Retrospective design.